Wikidata

(Q83154106)

English

Bcr-Abl resistance screening predicts a limited spectrum of point mutations to be associated with clinical resistance to the Abl kinase inhibitor nilotinib (AMN107)

scientific article published on 13 April 2006

In more languages

Statements

title
Bcr-Abl resistance screening predicts a limited spectrum of point mutations to be associated with clinical resistance to the Abl kinase inhibitor nilotinib (AMN107) (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
16614241
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614241%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 January 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q83154106&oldid=1232845029"